Morphosys Ag (MOR) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access MOR Annual Income Statement →
Reviewing income statement figures over time helps illustrate how Morphosys Ag generates earnings and manages operating expenses.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
Q4 2023
0 0 0 (Dec 31 2022)
Revenues
Total Revenue266.87
Costs & Expenses
Cost of Goods and Services Sold65.36
Gross Profit201.52
Selling, Administration, Marketing91.13
Research and Development Expense317.65
Other Operating Expense / -Income75.51
Total operating costs including COS549.64
Operating income / -loss-282.77
Net Interest Expense / -Income0.00
Other loss / -income-71.60
Total costs & expenses478.04
Income & Taxes
Income / -loss before income taxes-211.17
Income taxes expenses / -benefit1.33
Income after income taxes-212.50
Net income / -loss of other equity0.00
Income / -loss from continuing operations-212.50
Net income / -loss-212.50
Income / -loss to shareholder-212.50
Earnings Per Share
Basic EPS (excl. extra items)-6.19
Basic Net EPS-6.19
Basic shares outstanding (Mill. of Units)34.31
Diluted Net EPS-6.19
Diluted average shares (Mill. of Units)34.31
4 historic quarters locked

Sign in to unlock the full Morphosys Ag income statement history.

About MOR Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.